Additional information
Pale yellow Powder
2518153-95-0
ACI-020813
75.0-76.2°C
C11H12BrN3
266.14
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
N-propylamino-5-bromoquinoxaline
6-(2-imidazoline-2-ylidineamino)-1,2,3,4-tetrahydroquinoxalin-2,3-dione
2-Quinoxalinamine, 5-bromo-N-propyl





![TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)